Annual Report

Overview

The report presents 2021 as a year of record growth, including a $2.6 million revenue base, a $37.7 million equity raise and a $29.9 million year-end cash balance. It also highlights progress in clinical trials, manufacturing capacity and commercial adoption of Steriwave. The company describes ESG initiatives covering environmental responsibility, workplace safety, diversity and governance, including a Board comprising 25% women. Sustainability priorities include reducing waste, expanding biohazard recycling and improving environmentally responsible product and packaging design.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: Ends 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services